Literature DB >> 10407772

Neurochemistry and defects of biogenic amine neurotransmitter metabolism.

K Hyland1.   

Abstract

The purpose of the current review is to present a brief background examining the mechanisms controlling synthesis, storage, release and action of the biogenic amine neurotransmitters and to provide examples of newly defined conditions that expand our awareness of the diversity and complexity of the inherited diseases that affect these important regulators of central and peripheral homeostasis.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10407772     DOI： 10.1023/a:1005587719505

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


  48 in total

1.  Variant of dihydropteridine reductase deficiency without hyperphenylalaninaemia: effect of oral phenylalanine loading.

Authors:  N Blau; B Thöny; A Renneberg; J M Penzien; K Hyland; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

Review 2.  Drugs of abuse: anatomy, pharmacology and function of reward pathways.

Authors:  G F Koob
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

Review 3.  Serotonin and vasoconstrictor synergism.

Authors:  O Yildiz; J R Smith; R E Purdy
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

4.  Dihydropteridine reductase deficiency localized to the central nervous system.

Authors:  N Blau; B Thöny; A Renneberg; L A Arnold; K Hyland
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 5.  Evolution of the dopaminergic system and its relationships with the psychopathology of pleasure.

Authors:  L Pani; G L Gessa
Journal:  Int J Clin Pharmacol Res       Date:  1997

Review 6.  Vesicular neurotransmitter transporters: from bacteria to humans.

Authors:  S Schuldiner; A Shirvan; M Linial
Journal:  Physiol Rev       Date:  1995-04       Impact factor: 37.312

7.  Biochemical hallmarks of tyrosine hydroxylase deficiency.

Authors:  C Bräutigam; R A Wevers; R J Jansen; J A Smeitink; J F de Rijk-van Andel; F J Gabreëls; G F Hoffmann
Journal:  Clin Chem       Date:  1998-09       Impact factor: 8.327

8.  Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test.

Authors:  K Hyland; J S Fryburg; W G Wilson; E M Bebin; L A Arnold; R S Gunasekera; R D Jacobson; E Rost-Ruffner; J M Trugman
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

9.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.

Authors:  H Ichinose; T Ohye; E Takahashi; N Seki; T Hori; M Segawa; Y Nomura; K Endo; H Tanaka; S Tsuji
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

10.  Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome.

Authors:  A J Man in 't Veld; F Boomsma; P Moleman; M A Schalekamp
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321
View more
  3 in total

1.  Dopamine-Responsive Growth-Hormone Deficiency and Central Hypothyroidism in Sepiapterin Reductase Deficiency.

Authors:  Matthias Zielonka; Nawal Makhseed; Nenad Blau; Markus Bettendorf; Georg Friedrich Hoffmann; Thomas Opladen
Journal:  JIMD Rep       Date:  2015-05-26

2.  Outcome of tyrosinaemia type III.

Authors:  C J Ellaway; E Holme; S Standing; M A Preece; A Green; E Ploechl; M Ugarte; F K Trefz; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

3.  Sepiapterin reductase deficiency in a 2-year-old girl with incomplete response to treatment during short-term follow-up.

Authors:  K Kusmierska; E E W Jansen; C Jakobs; K Szymanska; E Malunowicz; D Meilei; B Thony; N Blau; J Tryfon; D Rokicki; E Pronicka; J Sykut-Cegielska
Journal:  J Inherit Metab Dis       Date:  2009-01-07       Impact factor: 4.982
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.